According to Actinium Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 27,058,397. At the end of 2023 the company had 27,058,397 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 27.05 M | 7.53% |
2022 | 25.16 M | 16.83% |
2021 | 21.53 M | 39.57% |
2020 | 15.43 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | 71,120,000 | 162.84% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | 295,759,435 | 993.04% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,866,000 | 597.99% | ๐บ๐ธ USA |